
Armentum Partners
Description
Armentum Partners is a specialized financial advisory firm headquartered in San Francisco, California, with a distinct focus on providing debt capital raising solutions. The firm primarily serves companies within the dynamic technology and healthcare sectors, offering strategic guidance and execution capabilities for a wide array of financing needs. Unlike traditional equity venture capital firms, Armentum Partners operates as an intermediary, leveraging its deep market knowledge and extensive network of debt providers to secure optimal funding for its clients.
The firm's expertise spans various stages of company growth, assisting both private, growth-stage enterprises and more mature public corporations. Armentum Partners helps structure and execute diverse debt facilities, including venture debt, growth capital, acquisition financing, and recapitalizations. Their advisory services are crucial for companies seeking non-dilutive capital or looking to optimize their balance sheets for strategic initiatives such as mergers, acquisitions, or significant expansion.
Armentum Partners' value proposition lies in its ability to navigate the complex landscape of debt markets, connecting clients with the most suitable lenders, which can include venture debt funds, commercial banks, and private credit funds. Through their advisory role, they aim to secure flexible and cost-effective debt solutions tailored to each client's specific objectives. For instance, the firm has successfully facilitated debt facilities ranging from approximately $10 million for growth capital needs to over $125 million for larger growth debt requirements, demonstrating their capacity to handle a broad spectrum of deal sizes. This strategic approach allows companies to access significant capital without diluting equity, supporting their long-term growth and operational stability.
Investor Profile
Armentum Partners has backed more than 116 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 3% of its total and boasts 68 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Debt Financing, Post Ipo Debt, Undisclosed rounds (top funding stages).
- Majority of deals are located in United States, Canada, Germany.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
- Typical check size: $10M – $125M.
Stage Focus
- Debt Financing (90%)
- Post Ipo Debt (9%)
- Undisclosed (1%)
Country Focus
- United States (86%)
- Canada (6%)
- Germany (3%)
- Ireland (2%)
- Israel (1%)
- Singapore (1%)
- Austria (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Medical
- Software
- E-commerce
- Manufacturing
- Therapeutics
- Saas
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.